Ossur hf (Ossur) designs, manufactures and sells non-invasive orthopedic products, specializing in prosthetics and bracing and support solutions. While the company’s products are available globally, the primary markets for the company are in North America and Europe. The company operates manufacturing facilities and offices across the Americas, Asia, and Europe, the Middle East and Africa (EMEA).

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Ossur focuses on the development of new and innovative products to expand its product portfolio. It focuses its efforts on developing solutions intended for the large population of elderly amputees. It aims to deliver cost-effective medical solutions that add value to end-users and the healthcare system with each product. The company majorly focuses on five key competencies namely, Bionic Technology, Carbon Composites, Silicon, Mechanics and Injection Molding. In collaboration with third parties, Ossur has continued to research in the field of augmenting systems. As of December 2023, the company spent US$38.1 million on R&D. Ossur has more than 2,100 patents in its IP portfolio. In addition, Ossur is protected by over 650 trademark registrations.